{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8TCB0",
      "entity_text" : "p44",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P32247",
      "entity_text" : "BRS-3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The BRS-3 agonist at 10 -11 M induced the maximal p42 / p44 MAPK and p90RSK1 phosphorylation, which was higher than that previously detected in cells from patients with T2D.",
  "reading_complete" : "2020-08-02T13:13:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:07:08Z",
  "trigger" : "induced",
  "evidence" : [ "BRS-3 agonist at 10 -11  M induced the maximal p42/p44 MAPK and p90RSK1 phosphorylation" ],
  "pmc_id" : "4356436",
  "score" : 0
}